The prognostic significance of intraperitoneal growth characteristics in epithelial ovarian carcinoma

International Journal of Gynecological Cancer

Volumn 6, Issue 3, 1996, Pages 219-224

  Van Geene, P ^a   Varma, R ^b   Dunn, J ^c   Chan, K K ^d   Luesley, D M ^a  

^a CITY HOSPITAL   (United Kingdom)

^b BASILDON HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

bulky spread; cytoreduction; prognosis; seedling

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0029969365     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06030219.x     Document Type: Article

References (19)

1. Office of Population Census and Surveys. Mortality statistics, serial tables. England and Wales 1841-1990. OPCS Series DH1 No 25 1992.
2. Griffiths C. Surgical resection of tumour bulk in the primary treatment of ovarian carcinoma. Symposium on ovarian cancer. Nat Cancer Inst Mongr 1975; 42: 1010-4.
3. Griffiths CT, Fuller A. Intensive surgical and chemotherapeutic management of ovarian carcinoma. Surg Clin N Am 1978; 58: 131-42.
4. Van Geene P, Luesley DM. Prospective randomised trials on cytoreduction in ovarian carcinoma. Ann of Med 1995; 27: 101-5.
5. Hunter RW, Alexander NDE, Soutter WP. Meta-analysis of surgery in advanced ovarian carcinoma: Is maximal cytoreductive surgery an independent determinant of prognosis? AM J Obstet Gynecol 1992; 166 (Suppl. 2): 504-18.
6. Rodriguez M, Nguyen H, Averette H, et al. National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer 1994; 73 (Suppl. 4): 1245-50.
7. Nelson B, Rosenfield A, Schwartz P. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol. 1993; 11 (Suppl. 1): 166-72.
8. Goodman H, Harlow B, Sheets E, et al. The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol. 1992; 46 (Suppl. 3): 367-71.
9. Unzelman R. Advanced epithelial ovarian carcinoma: long-term survival experience at the community hospital. Am J Obstet Gynecol. 1992; 166 (Suppl. 6 Pt 1): 1663-71.
10. Chen S, Bochner R. Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma. Gynecol Oncol 1985; 20: 190-5.
11. Neyt J, Ten Bokkel Huinink W, Van Den Burg M, et al. Randomised trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma. J Clin Oncol 1987; 5: 1157-68.
12. Lawton F, Luesley D, Redman C, Chan K, Varma R, Blackledge G. Feasibility and outcome of complete secondary tumour resection for patients with advanced ovarian carcinoma. J Surgical Oncology 1990; 45: (14-19).
13. Heintz A, Hacker N, Berek J, Rose T, Munoz A, Lagasse L. Cytoreductive surgery in ovarian carcinoma: Feasibility and Mortality. Obstet Gynecol 1986; 67 (Suppl. 6): 783-8.
14. Heintz A. Surgery in advanced ovarian carcinoma: is there proof to show the benefit. Eur J Surg Oncol 1988; 14: 91-9.
15. Dixon WJ, Brown MB, Engeman I, Jennrich RI. BMDP Statistical Software Manual. California: University of California Press, 1990.
16. Peto R, Pike MC, PA. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 1977; 35: 1-39.
17. Cox DR. Regression models and life tables. J Rep Stat 1972; 34: 187-220.
18. Hacker N, Berek J, Lagasse L, Nieberg R, Elashoff R. Primary cytoreductive surgery for epithelial ovarian carcinoma. Obstet Gynecol 1983; 61: 413-20.
19. Miller DS, Ballon SC, Teng NN, Seifer DB, Soriero OM. A critical reassessment of second-look laparotomy in epithelial ovarian carcinoma. Cancer 1986; 57: 530-5.